1. Home
  2. OCGN vs MPTI Comparison

OCGN vs MPTI Comparison

Compare OCGN & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • MPTI
  • Stock Information
  • Founded
  • OCGN 2013
  • MPTI 1965
  • Country
  • OCGN United States
  • MPTI United States
  • Employees
  • OCGN N/A
  • MPTI N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • MPTI
  • Sector
  • OCGN Health Care
  • MPTI
  • Exchange
  • OCGN Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • OCGN 189.6M
  • MPTI 166.8M
  • IPO Year
  • OCGN N/A
  • MPTI N/A
  • Fundamental
  • Price
  • OCGN $0.70
  • MPTI $44.05
  • Analyst Decision
  • OCGN Strong Buy
  • MPTI
  • Analyst Count
  • OCGN 3
  • MPTI 0
  • Target Price
  • OCGN $6.33
  • MPTI N/A
  • AVG Volume (30 Days)
  • OCGN 4.2M
  • MPTI 56.1K
  • Earning Date
  • OCGN 03-05-2025
  • MPTI 03-27-2025
  • Dividend Yield
  • OCGN N/A
  • MPTI N/A
  • EPS Growth
  • OCGN N/A
  • MPTI 107.03
  • EPS
  • OCGN N/A
  • MPTI 2.65
  • Revenue
  • OCGN $4,054,999.00
  • MPTI $49,012,000.00
  • Revenue This Year
  • OCGN N/A
  • MPTI $21.65
  • Revenue Next Year
  • OCGN N/A
  • MPTI $9.37
  • P/E Ratio
  • OCGN N/A
  • MPTI $16.42
  • Revenue Growth
  • OCGN N/A
  • MPTI 19.05
  • 52 Week Low
  • OCGN $0.52
  • MPTI $23.00
  • 52 Week High
  • OCGN $2.08
  • MPTI $71.10
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 53.03
  • MPTI 53.60
  • Support Level
  • OCGN $0.69
  • MPTI $38.88
  • Resistance Level
  • OCGN $0.80
  • MPTI $46.15
  • Average True Range (ATR)
  • OCGN 0.05
  • MPTI 3.74
  • MACD
  • OCGN 0.02
  • MPTI 1.04
  • Stochastic Oscillator
  • OCGN 58.35
  • MPTI 78.91

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: